Harrow Health (HROW) Gets a Buy From Craig-Hallum
Express News | Harrow to Attend 2024 Asrs Annual Meeting
Ionesi Group Offers Reliable Building Services in Harrow, Northwood, and Watford
Express News | Harrow Enters Into 340B Prime Vendor Program Contract With Apexus
Top 3 Health Care Stocks That May Crash This Quarter
Taaleem Signs Exclusive Operations, Ownership Deal With Harrow International Schools
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $30
Harrow Is Maintained at Buy by Craig-Hallum
Harrow Analyst Ratings
Express News | Harrow, Inc. : Craig-Hallum Raises Target Price to $30 From $26
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
Harrow Rises 15% In Pre-market
Market-Moving News for June 20th
Express News | Harrow Shares Are Trading Higher After the Company Announced the Manufacture of the First of Three Commercial-scale Process Performance Qualification Batches of TRIESENCE 40 Mg/mL. Also the Company Announced That the Second and Third Required PPQ...
Harrow Hopes To Relaunch Triesence This Year
Harrow Announce Manufacture Of First Of Three Commercial-Scale Process Performance Qualification Batches Of Triesence For Visualization During Vitrectomy And Ocular Inflammatory Conditions, Harrow Says Second & Third Required PPQ Batches Are Scheduled
Express News | Harrow: IF Ppq Batches Meet Specifications, New Triesence Production Process to Be Deemed Complete, Allowing Co to Relaunch During 2024
Express News | Harrow Inc: Successful Manufacture of Triesence Ppq Batch